Edition:
India

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.49USD
13 Dec 2017
Change (% chg)

$-0.12 (-2.14%)
Prev Close
$5.61
Open
$5.65
Day's High
$5.67
Day's Low
$5.46
Volume
33,191
Avg. Vol
152,191
52-wk High
$14.09
52-wk Low
$4.56

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.57 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 5 5 5 5
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.71 1.71 1.71

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 6 1.40 1.80 1.00 0.57
Quarter Ending Mar-18 4 1.62 2.30 1.00 --
Year Ending Dec-17 6 5.60 6.00 5.20 3.54
Year Ending Dec-18 6 5.67 9.50 2.90 3.70
Earnings (per share)
Quarter Ending Dec-17 6 -0.57 -0.48 -0.62 -0.59
Quarter Ending Mar-18 4 -0.57 -0.48 -0.63 --
Year Ending Dec-17 5 -2.61 -2.46 -3.06 -2.74
Year Ending Dec-18 6 -2.31 -1.85 -2.86 -12.22

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.22 1.47 0.25 20.65
Quarter Ending Jun-17 1.22 1.05 0.17 13.68
Quarter Ending Mar-17 1.49 1.68 0.19 12.75
Quarter Ending Dec-16 1.05 2.31 1.26 120.11
Quarter Ending Sep-16 1.16 0.97 0.19 16.37
Earnings (per share)
Quarter Ending Sep-17 -0.59 -0.79 0.20 -34.65
Quarter Ending Jun-17 -0.60 -0.54 0.06 -10.15
Quarter Ending Dec-16 -0.57 -0.69 0.12 -21.84
Quarter Ending Sep-16 -2.54 -0.66 1.88 -74.15
Quarter Ending Jun-16 -0.42 -0.55 0.13 -32.02

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.40 1.40 1.37 1.22 0.57
Quarter Ending Mar-18 1.62 1.62 1.47 1.05 --
Year Ending Dec-17 5.60 5.60 5.42 5.20 3.54
Year Ending Dec-18 5.67 5.67 5.88 5.75 3.70
Earnings (per share)
Quarter Ending Dec-17 -0.57 -0.57 -0.56 -0.47 -0.59
Quarter Ending Mar-18 -0.57 -0.57 -0.55 -0.45 --
Year Ending Dec-17 -2.61 -2.61 -2.49 -2.29 -2.74
Year Ending Dec-18 -2.31 -2.31 -2.16 -1.86 -12.22

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 1
Quarter Ending Mar-18 0 0 1 0
Year Ending Dec-17 0 0 2 1
Year Ending Dec-18 0 0 1 1
Earnings
Quarter Ending Dec-17 0 0 1 2
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 0 2
Year Ending Dec-18 0 0 1 2